RNU4-71P

Across TCGA pan-cancer cohorts, RNU4-71P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU4-71P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RNU4-71P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU4-71P expression acts as an unfavorable survival marker.

DLBC, KIRC, and LUAD are the cancer types where RNU4-71P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	II,III,IV	0.097	0.834	<.001	72	view →
KIRC	DFS	Tertile	IV	0.100	0.619	.004	36	view →
LUAD	DFS	Tertile	All	0.262	0.770	.001	36	view →
THCA	OS	Tertile	All	0.323	0.955	<.001	24	view →
UCS	OS	Tertile	All	0.153	0.687	.019	18	view →
LUSC	OS	Tertile	All	0.165	0.659	.025	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
SARC	DFS	Tertile	All	0.367	0.613	.007	18	view →
SKCM	OS	Tertile	II,III,IV	0.374	0.736	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU4-71P–DLBC (DFS)

Open the DLBC breakdown →